This activity is designed to inform healthcare professionals about issues related to adherence to oral oncology therapies.
Instructions For This Activity & Receiving Credit
|
This activity is directed toward hematologists, medical oncologists, nurses, and nurse practitioners who manage and treat patients with cancer. Transplantation specialists, radiation oncologists, pathologists, fellows, physician assistants, and other healthcare providers interested in the treatment of cancer are also invited to participate.
Cheryl Zigrand
Disclosure: No relevant financial relationships with commercial interests to disclose.
Debu Tripathy, MD
Professor of Medicine and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX
Disclosure: Grant/research support: Genentech/Roche, Pfizer, Puma Inc, Novartis (clinical trial support contracted to the University of Southern California and MD Anderson Cancer Center); consultant: Eisai, OncoPlex Diagnostics, Merck, Novartis.
Carol Blecher, MS, RN, AOCN, APNC, CBCN
Advanced Practice Nurse/Clinical Educator
Trinitas Comprehensive Cancer Center/Trinitas Regional Medical Center
Elizabeth, NJ
Disclosure: No relevant financial relationships with commercial interests to disclose.
Amit A. Patel, MD
Attending Physician, Hudson Hematology/Oncology
Chief, Department of Hematology/Oncology, Barnabas Health - Jersey City Medical Center
Chairman, Barnabus Health - Jersey City Medical Center Cancer Center Committee
Chairman, Jersey Medical Center Institutional Review Board
Clinical Assistant Professor of Medicine, Jersey City Medical Center - Mt. Sinai School of Medicine
Assistant Professor of Medicine, St George’s University School of Medicine
Clinical Assistant Professor of Medicine, New York Institute of Technology
Jersey City, NJ
Disclosure: Speaker’s bureau: Celgene
The staff of Physicians' Education Resource®, LLC (PER®) (Ann C. Lichti, CHCP, Michael Perlmutter, PharmD, MS, and Kerry Clayton) as well as the editorial staff of The American Journal of Hematology/Oncology® (Devera Pine) have no relevant financial relationships with commercial interests to disclose.
In accordance with Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial SupportSM, PER® resolved all conflicts of interest (COI) prior to the release of this CME activity using a multistep process.
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is funded by Physicians' Education Resource®, LLC.
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.